Donate Bitcoins to Folding@home
We’re grateful for all of the donations we get. Donors have often asked us for other ways to donate and we wanted to give a heads up on a new…
Read moreWe’re grateful for all of the donations we get. Donors have often asked us for other ways to donate and we wanted to give a heads up on a new…
Read moreIn our simulations, we use models (aka “force fields”) of how a protein’s atoms interact physically. Â Recently, we’ve made an important advance in how to make these models, which will,…
Read moreOur paper “Activation pathway of Src kinase reveals intermediate states as targets for drug design” in Nature Communications has just come out.  As with Nature journals, it’s unfortunately behind a pay…
Read moreThe Biophysical Society, an international group that brings together researchers taking a physical perspective on biology, just had its annual meeting in San Francisco. A number of us involved with…
Read moreThrough a collaboration with Google, the Huang lab at  UST Hong Kong, and the Pande Lab at Stanford University, we’ve been working on a new way to run Folding@home –– through the browser.  The primary…
Read moreI’ll be presenting a webinar on Folding@home open to the public on Tuesday, May 27, 2014 9:00 AM – 10:00 AM PDT. Â You can register on this link: https://www2.gotomeeting.com/register/688201986. Â The…
Read moreWe’ve been suspicious that the stats system has been undercounting ATI/AMD GPUs for some time now and we have found the issue. Â We’ve rolled out an update to the stats…
Read moreI recently gave a webinar on OpenMM, the heart of our Core17 for GPUs (and also now more recently, high performance computing on multi-core CPUs as well). Â Here’s a link…
Read moreOur recent work on simulating kinases on Folding@home and the simulation’s use in identifying potential new cancer drug targets has been just accepted for publication in Nature Communications this morning.  I’ll post…
Read moreWe’ve added a few papers to the Papers page. Â The most important application result is our work on GPCR intermediates as new possible drug targets. Â We also have several new…
Read more